FLGT

19.88

1.02% 0.20

Handel nachbörslich: 19.88

Fulgent Genetics Inc (FLGT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$19.68

Offen:

$19.72

24-Stunden-Volumen:

195.00K

Relative Volume:

0.48

Marktkapitalisierung:

$663.21M

Einnahmen:

$290.71M

Nettoeinkommen (Verlust:

$-163.43M

KGV:

-3.6277

EPS:

-5.48

Netto-Cashflow:

$11.70M

1W Leistung:

+2.85%

1M Leistung:

-4.05%

6M Leistung:

+7.63%

1J Leistung:

+1.33%

1-Tages-Spanne:

$19.57

$20.35

1-Wochen-Bereich:

$19.22

$20.35

52-Wochen-Spanne:

$14.76

$25.11

Fulgent Genetics Inc Stock (FLGT) Company Profile

Firmenname

Fulgent Genetics Inc

Sektor

Healthcare (1173)

Branche

Diagnostics & Research (54)

Telefon

626-350-0537

Adresse

4399 SANTA ANITA AVE, EL MONTE

Mitarbeiter

1,313

Twitter

@FulgentGenetics

Nächster Verdiensttermin

2025-05-02

Neueste SEC-Einreichungen

FLGT's Discussions on Twitter

Vergleichen Sie FLGT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FLGT Fulgent Genetics Inc	19.88	663.21M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	405.46	156.49B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	197.54	145.01B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	536.34	42.30B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	118.01	34.24B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	157.59	27.64B	15.50B	1.33B	2.16B	7.34

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-12-07	Eingeleitet	UBS	Neutral
2022-12-08	Herabstufung	Piper Sandler	Overweight → Neutral
2022-11-18	Eingeleitet	Raymond James	Outperform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-02-04	Fortgesetzt	Piper Sandler	Overweight
2021-08-05	Fortgesetzt	Credit Suisse	Underperform
2021-01-08	Herabstufung	Credit Suisse	Neutral → Underperform
2020-11-24	Herabstufung	BTIG Research	Buy → Neutral
2020-08-20	Eingeleitet	Oppenheimer	Outperform
2020-05-29	Eingeleitet	BTIG Research	Buy
2019-11-05	Hochstufung	Piper Jaffray	Neutral → Overweight
2018-03-01	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-11-07	Herabstufung	Raymond James	Outperform → Mkt Perform

Alle ansehen

Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten

Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent - Bluefield Daily Telegraph

Jun 18, 2025

Jun 16, 2025

GAMMA Investing LLC Acquires 72,261 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jun 16, 2025

Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent ... - Bluefield Daily Telegraph

Jun 15, 2025

Jun 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire

Jun 12, 2025

Jun 11, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 5,986 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jun 11, 2025

Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fulgent Genetics, Inc. (FLGT) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 10, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, - GlobeNewswire

Jun 10, 2025

Jun 09, 2025

Bragar Eagel & Squire, P.C. Is Investigating Semler, ADTRAN, and Fulgent and Encourages ... - Bluefield Daily Telegraph

Jun 09, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulgent Genetics, Inc. (FLGT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jun 09, 2025

Jun 08, 2025

Bank of America Corp DE Has $1.48 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Jun 08, 2025